HealthDecember 08, 2020

Wolters Kluwer targets precision dosing with Tabula Rasa HealthCare’s DoseMeRx integration

Wolters Kluwer, Health, a global provider of trusted clinical technology and evidence-based solutions, has announced the integration of DoseMeRx™, a Tabula Rasa Healthcare precision dosing solution, with Sentri7’s Antimicrobial Stewardship (AMS) solution. With a single click, pharmacists can review patient-specific parenteral vancomycin dose recommendations calculated automatically using key clinical data such as patient weight, laboratory values, creatinine levels and drug administration times.

“Dosing and monitoring of vancomycin can be complex, requiring patient data and laboratory results to individualize the dose for each patient,” said Charles Cornish, Executive Vice President, Hospitals Business Unit, TRHC. “By integrating our precision dosing platform with Wolters Kluwer’s Sentri7 solution, pharmacists across the country will have convenient, integrated real-time Bayesian dosing support to align with the best practices in the American Society of Health System Pharmacists 2020 guideline recommendation for dosing and monitoring of vancomycin.”

Vancomycin is one of the most commonly used antibiotics in hospitals today. Traditionally, calculating vancomycin doses for patients requires coordination among pharmacists, nurses, and laboratory technicians, as well as manual calculations that are time-consuming. With the DoseMeRx integration, pharmacists have automated access to faster, more precise calculations, without any data entry, and proactively monitor for adjustments to reduce a patient’s risk of acute kidney injury.

“Pharmacists are routinely challenged by how best to avoid adverse drug events in patients. By improving the methodology for precision dosing, pharmacists can focus on delivering the best possible patient care,” said Karen Kobelski, Vice President and General Manager, Clinical Surveillance, Compliance & Data Solutions at Wolters Kluwer, Health.“With the seamless transfer of patient specific parameters between Sentri7 and DoseMeRx, clinical teams have the expert solutions they need to predict more accurate drug concentration over time.”

In addition to the DoseMeRx real-time vancomycin dosing platform, pharmacists can leverage Sentri7’s evidence-based AMS rules to assess appropriate vancomycin use and keep prescribing in line with their hospital’s antimicrobial stewardship goals and the CDC’s Core Elements of Antimicrobial Stewardship program.

Click here to learn more about Sentri7’s Antimicrobial Stewardship (AMS) solution.

Learn More About Sentri7

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

André Rebelo
Andre Rebelo
Director, External Communications
Back To Top